Sangamo Therapeutics Inc - Company Profile

Powered by

All the data and insights you need on Sangamo Therapeutics Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Sangamo Therapeutics Inc Strategy Report

  • Understand Sangamo Therapeutics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Sangamo Therapeutics Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a biotechnology company that focuses on the research, development, and commercialization of engineered DNA-binding protein Zinc Finger Transcription (ZFPs). Its ZFPs candidates are based on its proprietary gene therapy technologies. It is advancing its pipeline candidates for the treatment of hemophilia A and B, Huntington's disease, Fabry disease, Alzheimer's disease, and others. Its ZFPs-based products are used in various applications such as human therapeutics, research reagents, pharmaceutical protein production, plant agriculture, cell-line engineering, and the production of transgenic animals. Sangamo is headquartered in Richmond, California, the US.

Gain a 360-degree view of Sangamo Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Sangamo Therapeutics Inc and make more informed decisions for your business Find out more
Headquarters United States of America

Address 501 Canal Blvd., Richmond, California, 94084


Telephone 1 510 9706000

No of Employees 405

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange SGMO (NASD)

Revenue (2022) $176.2M 58.3% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ -34.1% (2022 vs 2021)

Market Cap* $93.5M

Net Profit Margin (2022) XYZ 15.3% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Sangamo Therapeutics Inc premium industry data and analytics

60+

Pipeline Drugs

Identify which of Sangamo Therapeutics Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

40+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Sangamo Therapeutics Inc’s relevant decision makers and contact details.

40+

Clinical Trials

Determine Sangamo Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

30+

Catalyst Calendar

Proactively evaluate Sangamo Therapeutics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

30+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

9

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Sangamo Therapeutics Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Pipeline Sangamo
ZFP Therapeutic Pipeline: ZFP Therapeutic
SB-525:
XYZ
XYZ
XYZ
Understand Sangamo Therapeutics Inc portfolio and identify potential areas for collaboration Understand Sangamo Therapeutics Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In July, the company entered into an agreement with Chroma Medicine to develop epigenetic medicines leveraging zinc finger proteins (ZFPs) for sequence-specific DNA recognition.
2023 Contracts/Agreements In June, the company entered into an agreement with Voyager Therapeutics for epigenetic regulation treatment of prion disease.
2023 Regulatory Approval In May, the company was granted Fast Track Designation by the US FDA for the treatment of fabry disease.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Sangamo Therapeutics Inc Merck & Co Inc Pfizer Inc GSK plc Amgen Inc
Headquarters United States of America United States of America United States of America United Kingdom United States of America
City Richmond Rahway New York Brentford Thousand Oaks
State/Province California New Jersey New York England California
No. of Employees 405 72,000 88,000 70,212 26,700
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Sandy Macrae, Ph.D. President; Director; Chief Executive Officer Executive Board 2016 61
H. Stewart Parker Chairperson Executive Board 2017 68
Prathyusha Duraibabu Chief Financial Officer; Senior Vice President Senior Management 2021 45
Mark McClung Chief Operating Officer; Executive Vice President Senior Management 2021 60
Whitney Jones Chief People Officer; Senior Vice President Senior Management 2020 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Sangamo Therapeutics Inc key executives to enhance your sales strategy Gain insight into Sangamo Therapeutics Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer